Endpoint definition
↥| Name | C3_ENDOCRINE |
|---|---|
| Long name | Malignant neoplasm of endocrine gland |
| Include | C3_THYROID_GLAND, C3_ADRENAL_GLAND, C3_ENDOCRINE_NAS |
| Level in the ICD-hierarchy | 2 |
| First defined in version | DF4 |
Malignant neoplasm of endocrine gland
endocrine neoplasm: A benign or malignant neoplasm arising from the epithelial cells of an endocrine organ. Representative examples include pituitary gland adenoma, pituitary gland carcinoma, thyroid gland carcinoma, carcinoid tumor, and neuroendocrine carcinoma.
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1069 | 805 | 264 |
| Unadjusted prevalence (%) | 0.49 | 0.66 | 0.28 |
| Mean age at first event (years) | 49.05 | 48.21 | 51.62 |
| Case fatality at 5-years (%) | 3.27 | 2.24 | 6.44 |
Longitudinal metrics
| All | Female | Male | |
|---|---|---|---|
| Median nb. of events per indiv. | 1.0 | 1.0 | 1.0 |
| Recurrence at 6 months (%) | 0.28 | 0.25 | 0.38 |
Survival analyses between endpoints
↥Plot
before Malignant neoplasm of endocrine gland
after Malignant neoplasm of endocrine gland
Loading survival analyses plot…
Table
Loading survival analyses table…